The rate of recurrence of bleeding or iron deficiency anemia in patients with significant findings P2 was 53% while it was 35% for those with other CE results P0, P1.
Comparando las tasas de recurrencia de sangrado o anemia ferropénica entre pacientes con hallazgos significativos P2 y aquellos con resultados de CE no relevantes P0, P1, fueron 53% y 35%, respectivamente.